Canada · Health Canada Drug Product Database
SERINE
Source ingredient · 75 source records
Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.
AMINOSYN II 7% WITH 10% DEXTROSE
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II 7% WITH 50% DEXTROSE
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II 8.5% INJECTION
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II 8.5% M IN 20% DEXTROSE (DUAL CHAMBER)
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II 8.5% WITH 50% DEXTROSE
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II IN DEXTROSE INJECTION
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II IN DEXTROSE INJECTION
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II IN DEXTROSE INJECTION
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II WITH ELECTROLYTES IN DEXTROSE INJECTION WITH CALCIUM
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II WITH ELECTROLYTES IN DEXTROSE INJECTION WITH CALCIUM
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN II WITH ELECTROLYTES IN DEXTROSE WITH CALCIUM
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN-PF 10%
Solution / HOSPIRA HEALTHCARE ULC
AMINOSYN-PF 7%
Solution / HOSPIRA HEALTHCARE ULC
CLINIMIX
Solution / BAXTER CORPORATION
CLINIMIX
Solution / BAXTER CORPORATION
CLINIMIX
Solution / BAXTER CORPORATION
CLINIMIX
Solution / BAXTER CORPORATION
CLINIMIX
Solution / BAXTER CORPORATION
CLINIMIX 2.5% TRAVASOL AA WITHOUT ELECTROLYTES IN 10% DEXTROSE INJEC
Solution / BAXTER CORPORATION CLINTEC NUTRITION DIVISION
CLINIMIX E
Solution / BAXTER CORPORATION
CLINIMIX E
Solution / BAXTER CORPORATION
CLINIMIX E
Solution / BAXTER CORPORATION
CLINIMIX E
Solution / BAXTER CORPORATION
CLINIMIX E
Solution / BAXTER CORPORATION
ESSEPNA
Solution / FRESENIUS KABI CANADA LTD
NUTRINEAL PD4
Liquid / BAXTER CORPORATION
OLIMEL 3.3% E
Emulsion / BAXTER CORPORATION
OLIMEL 4.4%
Emulsion / BAXTER CORPORATION
OLIMEL 4.4% E
Emulsion / BAXTER CORPORATION
OLIMEL 5.7%
Emulsion / BAXTER CORPORATION